Indokem Q1 FY27 results: revenue and profit grow year on year
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 4.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indokem Limited reported Q1 FY27 (ended June 30, 2026) standalone revenue of Rs 4,252 lakhs, up 17 percent from Rs 3,632 lakhs in Q1 FY26. Standalone PBT rose to Rs 86 lakhs from Rs 33 lakhs. Total expenses grew to Rs 4,187 lakhs. Consolidated revenue was Rs 4,663 lakhs vs Rs 4,157 lakhs, with consolidated PBT at Rs 108 lakhs vs Rs 70 lakhs. EPS stood at Rs 0.31 on standalone basis. Statutory auditor CNK and Associates LLP issued an unmodified limited review report.
Strong year on year profit growth on better revenue and cost control may support sentiment, though overall margins remain thin.